EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early development of the Tsc1 Purkinje cell specific mouse knockouts

Anna Sługocka, Marta Anna Przybyła, Jarosław Jerzy Barski

Acta Neurobiologiae Experimentalis · 2023

DOI: 10.55782/ane-2023-2472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, 2023. Verfasst von Anna Sługocka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department for Experimental Medicine, Medical University of Silesia, Katowice, Poland; Department of Physiology, School of Medicine in Katowice, Medi…. Hauptthemen laut MEDLINE: Autistic Disorder, Purkinje Cells, Tuberous Sclerosis Complex 1 Protein. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tsc1 is a gene which expression results in hamartin, a protein involved in regulation of the mTOR1 pathway. Inactivation of Tsc1 gives rise to hyperactivation of the mTOR1 machinery, increased proliferation and growth of cells with subsequent cell degeneration and cell death. In humans, mutations of Tsc1 result in an inherited disorder ‑ tuberous sclerosis complex (TSC) with the concomitant multiorgan non‑malignant tumors (tubers), epileptic seizures and autistic‑like manifestations. General mouse knock‑outs, homozygous for the inactivated Tsc1 alleles do not survive and die at early embryonal stages. To circumvent this problem, we utilized the Cre/loxP system and removed Tsc1 specifically in Purkinje cells using the pcp2/L7Cre mouse strain and the Tsc1tmDjk/J strains. Because of the published results showing the autistic‑like symptoms after the same crossbred, we have decided to look closer at the early postnatal period of these mutants. Surprisingly no evidence of any behavioral alterations were found, including the ultrasonic vocalizations of newborns. We decided to focus more attention on the interpretation of data, including a more detailed statistical evaluation of our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autistic DisorderPurkinje CellsTuberous Sclerosis Complex 1 ProteinAnimalsMiceAllelesMutationSeizuresMice, Knockout

Substanzen

Tsc1 protein, mouseTuberous Sclerosis Complex 1 Protein

Autor:innen und Institutionen

  • Department for Experimental Medicine, Medical University of Silesia, Katowice, Poland; Department of Physiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. e@d.e.
  • Department for Experimental Medicine, Medical University of Silesia, Katowice, Poland; Laboratory of Molecular Biology, Institute of Physiotherapy and Health Science, Academy of Physical Education, Katowice, Poland. e@d…
  • Department for Experimental Medicine, Medical University of Silesia, Katowice, Poland; Department of Physiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. jbarski@sum.edu.pl.

Zitieren

APA

Sługocka, A., Przybyła, M. A., & Barski, J. J. (2023). Early development of the Tsc1 Purkinje cell specific mouse knockouts. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/ane-2023-2472

Vancouver

Sługocka A, Przybyła MA, Barski JJ. Early development of the Tsc1 Purkinje cell specific mouse knockouts. Acta Neurobiologiae Experimentalis. 2023. doi:10.55782/ane-2023-2472

BibTeX
@article{Sugocka2023,
  author = {Sługocka, Anna and Przybyła, Marta Anna and Barski, Jarosław Jerzy},
  title = {Early development of the Tsc1 Purkinje cell specific mouse knockouts},
  journal = {Acta Neurobiologiae Experimentalis},
  year = {2023},
  doi = {10.55782/ane-2023-2472}
}
Kostenlos starten →